Maria Rosario G. C.
- Country
- Spain
- Department
- Servicio de Oncologia Médica
Research Overview
- Evaluation of Debio 0123 Combined with Carboplatin and Etoposide in Adults with Recurrent or Progressive Small Cell Lung Cancer Post-Platinum Therapy
- Evaluation of MEDI5752 in Patients with Advanced Solid Tumors: A Clinical Trial
- Evaluation of Trastuzumab Deruxtecan and Pembrolizumab in Patients with Locally Advanced or Metastatic Breast Cancer or Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 500 of 750 partner sites.
Specializations
Advanced Lung Cancer
This investigator specializes in treating metastatic non-small cell lung cancer (NSCLC) and extensive-stage small cell lung cancer (ES-SCLC), with particular emphasis on advanced disease states.
- Metastatic NSCLC management
- Stage IV NSCLC treatment approaches
- ALK-positive NSCLC interventions
Their work encompasses both treatment-naïve and previously treated patient populations.
Immunotherapy Applications
The investigator focuses on novel immunotherapeutic approaches in lung cancer treatment, particularly involving combination immunotherapy strategies.
- Pembrolizumab-based therapies
- Nivolumab and ipilimumab combinations
- PD-L1 targeted treatments
Their expertise extends to immunotherapy integration with conventional treatment modalities.
Therapeutic Innovation
The investigator explores innovative therapeutic combinations and novel investigational agents for treating various forms of lung cancer.
- Advanced solid tumor therapies
- Targeted molecular treatments
- Chemotherapy combination strategies
Their research includes evaluation of new therapeutic approaches for treatment-resistant cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.